Truvian Sciences Appoints Top Industry Veterans to its Leadership Team as it Prepares to Commercialize its Automated Benchtop Blood Testing System

Truvian Sciences (Truvian) today announced four executive appointments that bring expanded industry and commercialization experience to the company as it advances toward submitting for U.S. Food and Drug Administration (FDA) clearance of its automated benchtop blood testing system.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Thursday, April 21, 2022
Information
Tags: 
Health, Biotechnology, West Virginia University, CEO, M.E, California State Polytechnic University, Pomona, Brigham Young University, Corporate Accountability, Research, Operation, Rady School of Management, Harvard Business School, Food, Leadership, Oncology, Arena Pharmaceuticals, Program, Amylin Pharmaceuticals, M.B.A, Indian Institute of Technology (BHU) Varanasi, Growth, Blood, Science, Global Sales Law Project, Arena, Food and Drug Administration, Health technology, PDL, Mechanical engineering, Operations research, Atlantic University, Business development, Virginia University, FDA, Industry, Senior, Institute, Florida Atlantic University, Business, SVKM's NMIMS, Head, Sumitomo Dainippon Pharma, Pharmaceutical industry, Management, Engineering, Technology, Illumina, Northwestern University, Biotechnology
Geotags: 
UNITED STATES, NORTH AMERICA, CALIFORNIA, WEST VIRGINIA, AJAY
Summary
Key Points: 
  • Truvian Sciences (Truvian) today announced four executive appointments that bring expanded industry and commercialization experience to the company as it advances toward submitting for U.S. Food and Drug Administration (FDA) clearance of its automated benchtop blood testing system.
  • Truvian is at a pivotal point in our company evolution as we progress towards global regulatory approvals and commercialization of our benchtop blood testing system, said Jeff Hawkins, President and CEO of Truvian.
  • Tyler Jensen brings more than 25 years of leadership and expertise in engineering and research and development to Truvian.
  • Its automated benchtop system is being developed to produce lab-accurate results for a full suite of health tests using a small sample of blood.


Truvian Sciences (“Truvian”) today announced four executive appointments that bring expanded industry and commercialization experience to the company as it advances toward submitting for U.S. Food and Drug Administration (FDA) clearance of its automated benchtop blood testing system.

Truvian has appointed Ajay Bansal as Chief Financial Officer, Tyler Jensen as Chief Product Officer, Joe Benson as Vice President of Strategy and Portfolio Management, and Eric Zieger as Vice President of Global Sales. Complementing the executive appointments, Truvian announced existing team members Jay Srinivasan has been named Chief Strategy Officer, and Co-founder Dena Marrinucci has been named Chief Science Officer.

“Truvian is at a pivotal point in our company evolution as we progress towards global regulatory approvals and commercialization of our benchtop blood testing system,” said Jeff Hawkins, President and CEO of Truvian. “The appointments of Ajay, Tyler, Joe and Eric will prove invaluable to Truvian as we accelerate our growth and expansion through the commercialization of our system and make routine testing more convenient and accessible for all.”

Ajay Bansal has served as a Chief Financial Officer at biotechnology companies for nearly 20 years. Most recently, he was Chief Financial Officer and Head of Business Development at Urovant Sciences, which was acquired by Dainippon Sumitomo Pharma in March 2021. Ajay holds a B.Tech. in Mechanical Engineering from the Indian Institute of Technology, New Delhi, an M.S. in Operations Research from Northwestern University and an M.B.A. from the Kellogg Graduate School of Management.

Tyler Jensen brings more than 25 years of leadership and expertise in engineering and research and development to Truvian. Most recently, Tyler served as Senior Vice President of Engineering and Product Technical Support for GenMark Diagnostics, which he joined in 2013. Tyler holds a B.S. in Design Engineering Technology from Brigham Young University and a M.E. in Mechanical Engineering from Florida Atlantic University.

Joe Benson has more than 20 years of experience in the life sciences and biopharma industries. Most recently, he served as Head of R&D Strategy and Operations at Arena Pharmaceuticals, where he provided leadership in the evaluation and execution of portfolio and program management, new product planning, and business operations. Prior to Arena, Joe led portfolio planning and prioritization efforts in the Oncology business unit and Clinical Genomics division at Illumina. He has also held a variety of leadership roles at Amylin Pharmaceuticals, PDL BioPharma, and as a management consultant to the biotechnology industry. Joe holds a B.S. in Biotechnology from California State Polytechnic University, Pomona and an M.B.A from the Rady School of Management.

Eric Zieger has more than 15 years of experience as a demonstrated leader in strategic life sciences sales, consistently exceeding sales targets and achieving top sales honors. Prior to Truvian, Eric served as Director of Strategic and Corporate Accounts for GenMark Diagnostics and formerly held various sales positions with Roche Tissue Diagnostics. Eric holds a B.S. in Medical Technology from West Virginia University and a certificate of completion from Harvard Business School for its Leadership Principles program.

About Truvian Sciences

Truvian is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system is being developed to produce lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian’s system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions. Truvian was founded by individuals with deep domain experience in healthcare, diagnostics and consumer technology. Today, the team has expanded to include top scientists, engineers and healthcare business leaders — each bringing specialized expertise to drive Truvian’s mission of making routine health testing convenient, affordable, and actionable.

Copyright: 
Copyright Business Wire 2022